Charles River Laboratories International Inc
XMUN:RV6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Charles River Laboratories International Inc
XMUN:RV6
|
US |
|
G
|
Genworth Financial Inc
F:GGK
|
US |
|
U
|
United Labels AG
XMUN:ULC
|
DE |
|
P
|
Plus Therapeutics Inc
F:XMPA
|
US |
|
D
|
DKSH Holding AG
XMUN:DS5
|
CH |
|
WA Kaolin Ltd
F:YC7
|
AU |
Wall St Price Targets
RV6 Price Targets Summary
Charles River Laboratories International Inc
According to Wall Street analysts, the average 1-year price target for RV6 is 187.97 EUR with a low forecast of 124.51 EUR and a high forecast of 239.67 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV6's stock price target?
Price Target
187.97
EUR
According to Wall Street analysts, the average 1-year price target for RV6 is 187.97 EUR with a low forecast of 124.51 EUR and a high forecast of 239.67 EUR.
What is the Revenue forecast for Charles River Laboratories International Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Charles River Laboratories International Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Charles River Laboratories International Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 21%.
